STOCK-BASED COMPENSATION (Tables)

3 Months Ended

Mar. 31, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Stock Option Activity

The following table summarizes the Company’s stock option activity during the periods presented (in thousands except share and per share data):

	Number of options	Weighted  average  exercise  price  ($)	Weighted average remaining contractual term (years)	Aggregate intrinsic value ($)
Outstanding as of December 31, 2024	10,984,738	1.67	6.64	75,270
Granted	—	—
Exercised	(26,042)	0.89
Forfeited and expired	(5,829)	0.85
Outstanding as of March 31, 2025	10,952,867	1.67	6.39	66,892
Options exercisable as of March 31, 2025	9,560,074	1.51	6.10	59,661
Options unvested as of March 31, 2025	1,392,793	2.72	8.38	7,230

Schedule of RSU Activity and Related Information

The following table summarizes the restricted stock unit ("RSU") activity and related information under the 2022 Plan (in thousands except share and per share data):

	Number of RSUs	Weighted average Grant Date Fair Value ($)
Unvested as of December 31, 2024	8,787,022	2.25
Granted	3,758,163	9.67
Forfeited and expired	(65,524)	3.16
Vested	(1,236,719)	1.82
Unvested as of March 31, 2025	11,242,942	4.77

Schedule of Stock-Based Compensation Expense

The following table summarizes the stock-based compensation expense classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):

	Three Months Ended March 31,
	2025		2024
Cost of revenue	$	142	$	175
Research and development	1,454		1,121
General and administrative	1,817		1,958
Sales and marketing	580		255
Total stock-based compensation	$	3,993	$	3,509